X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Partnerships are driving global COVID-19 treatment access

By Megan Van Etten  |    September 22, 2022
Through the constant efforts of U.S. innovators and their global partners, COVID-19 treatments have continued to be distributed to patients around the world — changing the pandemic’s treatment...   Read More

The dangers of expanding the TRIPS waiver

By Megan Van Etten  |    September 19, 2022
World Trade Organization (WTO) members, including the United States, are considering waiving commitments to honor certain intellectual property (IP) rights on COVID-19 treatments, following a harmful...   Read More

Biden Administration details inadequate protection of American intellectual property and foreign barriers to innovation abroad

By Ernest Kawka  |    April 29, 2022
More than two years into the COVID-19 pandemic, the world has witnessed the immense value of biopharmaceutical innovation. With numerous safe and effective vaccines and treatments developed in record...   Read More

PhRMA encourages Biden administration to pursue ambitious Indo-Pacific Economic Framework

By Douglas Petersen  |    April 13, 2022
Last fall, President Biden announced that the United States would explore development of an Indo-Pacific Economic Framework (IPEF) to deepen economic relations in the region and collaborate to...   Read More

PhRMA submission to 2022 National Trade Estimate Report underscores need for pro-innovation U.S. trade policy to combat COVID-19 and other diseases

By Douglas Petersen  |    October 29, 2021
The biopharmaceutical industry has been working tirelessly to develop and manufacture innovative vaccines, therapies and diagnostics to combat COVID-19 and other diseases and illnesses. As of October...   Read More

Strengthening the WTOs global trade and health agenda

By Douglas Petersen  |    October 18, 2021
The World Trade Organization (WTO) should use the weeks ahead to focus on delivering an ambitious and productive trade and health agenda as it prepares for the Twelfth Ministerial Conference (MC12)...   Read More

New polling shows Americans are sounding the alarm on the TRIPS IP waiver

By Cynthia Hicks  |    May 14, 2021
Last week, the Biden administration announced support for a waiver of the World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, which could lead to...   Read More

The Biden Administration allows politics to upend a pragmatic pandemic response

By Megan Van Etten  |    May 14, 2021
Last week, the Biden Administration announced that it will support a waiver of the World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, which would...   Read More

American leadership on innovation policy is essential to global health progress

By Ernest Kawka  |    May 4, 2021
Over the last year, the world has witnessed the importance of strong innovation policies as intellectual property protection and market access policies facilitated the research, development and...   Read More

Preserving U.S. innovation worldwide is more important than ever

By Megan Van Etten  |    January 29, 2021
The COVID-19 pandemic has spurred unprecedented levels of innovation within the biopharmaceutical industry to combat this urgent global health crisis. PhRMA member companies are collaborating with...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates